In contrast, the downregulated group of FBN2 gene is consistently correlated with the shorter survival of colon cancer patients in GSE17536 (Figure 4C), indicating the tumor-suppressive role of FBN2 in colon cancer. This evidence concerns the gene FBN2 and malignant colon neoplasm.